[Incorporation of auxin into swollen lecithin lamellae].
Explore the source record for details and available documents.
Arachidonic Acids↗
SEARCH · PubMed Health
Results for “VALERIC ACID”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
[Trial of a new antiepileptic drug, magnesium dipropyl acetate].
Explore the source record for details and available documents.
Adolescent↗
Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate.
Explore the source record for details and available documents.
Adult↗
2,4-diaminopentanoic acid C 4 dehydrogenase. Purification and properties of the protein.
Explore the source record for details and available documents.
Amino Acid Oxidoreductases↗
Proceedings: A controlled trial of sodium valproate in severe epilepsy.
Explore the source record for details and available documents.
Clinical Trials as Topic↗
Proceedings: Sodium valproate (Epilim) and photosensitivity. A preliminary report.
Explore the source record for details and available documents.
Electroencephalography↗
Proceedings: Sodium valproate (Epilim) in the treatment of intractable epilepsy, including some observations on blood levels.
Explore the source record for details and available documents.
Epilepsy↗
Proceedings: The effect of sodium valproate (Epilim) on the EEG.
Explore the source record for details and available documents.
Electroencephalography↗
Comparison of the central nervous system actions of taurine and N-pivaloyltaurine [proceedings].
Explore the source record for details and available documents.
Animals↗
[Excretion of gamma delta-dioxovalerianic acid and delta-aminolaevulinic acid in various disorders of haem synthess].
Explore the source record for details and available documents.
Acute Disease↗
[Biochemical diagnosis in ascariasis].
Explore the source record for details and available documents.
Adult↗
A polarographic examination of some pyruvic acid homologues.
Explore the source record for details and available documents.
Buffers↗
Isolation and identification of 2,5-dioxovalerate, an intermediate in the bacterial oxidation of hydroxyproline.
Explore the source record for details and available documents.
Chromatography, Paper↗
A comparison of the effects of allylglycine and 2-keto-4-pentenoic acid on cerebral glutamic acid decarboxylase activity and convulsions in mice [proceedings].
Explore the source record for details and available documents.
Animals↗
Profiles of urinary volatiles from metabolic disorders characterized by unusual odors.
The profiles of urinary volatiles from patients with phenylketonuria, maple syrup urine disease, isovaleric acidemia, or trimethylaminuria (fish-odor syndrome) were in each case vastly different from the normal urinary volatiles profile. In the maple syrup urine disease case, metabolites that occur distal to the block were found and a mechanism for their formation is suggested. A new major metabolite in isovaleric acidemia was also found. As well as providing a reliable diagnostic tool for diseases characterized by odors, the analysis of urinary volatiles may provide information to help our understanding of still unexplained aspects of the diseases.
Adolescent↗
Gemfibrozil--a new lipid lowering agent.
Thirty patients with type II and IV hyperlidemia were studied by a double blind cross over technic. Gemfibrozil at dosages of 1200 mg and 1600 mg a day was compared to 2000 mg daily of clofibrate. The effect of each drug regimen is described for the entire study population and for those who were found to be responders.
Cholesterol↗
Gemfibrozil for hyperlipidemia.
Explore the source record for details and available documents.
Cholesterol↗
Effect of gemfibrozil on serum lipid levels.
A short term investigation of the effect of Gemfibrozil in 1200 mg daily doses has been carried out in a group of 20 Swedish males, 9 Lp[a+] and 11 Lp[a-]. The effect of 8 weeks of treatment upon serum lipids resembled those found in previous trials, with a significant decrease in serum total cholesterol. In this series, even VLDL cholesterol and apoB levels decreased significantly. With the apparent exception of HDL cholesterol, there was no suggestion that Lp[a+] individuals responded less well to treatment than did Lp[a-] individuals.
Cholesterol↗